Back to R2 link
Top Industry News
- FDA Finalizes Guidance on Charging for Investigational Drugs Under an IND Questions and Answers
- Launch of New HMA-EMA Catalogues of Real-World Data Sources and Studies
- MHRA Performance Data for Assessment of Clinical Trials and Established Medicines
- MHRA Request for Regulators to Publish an Update on Their Strategic Approach to AI: Secretary of State letters
- ECHA Seeks Feedback on Proposed Recommendation of Five Substances for REACH Authorization
- The ANSM Creation of a Temporary Scientific Committee to Define the Conditions for the Substitution of Biosimilar Drugs
- SFDA Guidance for Priority Review of Product Registration
- PMDA - Submission of Clinical Trial Plan Notifications During the Holidays from the End of April to the Beginning of May
- PMDA - The Schedule for New OTC Drug Development Validity Consultation Has Been Posted
- MHRA Register of Licensed Manufacturing Sites
- FDA Use of Data Monitoring Committees in Clinical Trials
- PMDA Medical Safety Information Has Been Published
- EU Parliament Passes Resolution Urging Swift Implementation of Health Claim Regulation for Improved Food Labeling and Consumer Protection
- Commission Initiates 4-Week Feedback Period on Banning BPA in Food Contact Materials as Part of EFSA's Food Safety Measures
- New Zealand - Updated Cosmetic Products Group Standard (CPGS)
- Are you Looking for Opportunities within the Canadian Market?
- Draft Technical Standards on Citrus Fruits Requirements Released by Peru
- MDA Gazette of The Medical Devices (Compounding Of Faults) Regulations 2024
- SWISSMEDIC Overview